Pros on CNBC discussed Biogen after the Food and Drug Administration approved its Alzheimer’s drug.
Powerball jackpot soars to $615 million. Here’s how much the winner could owe in taxes
If you win the Powerball jackpot, your winnings will shrink after the IRS cut. Here’s what to know.
Fed’s Goolsbee sees ‘golden path’ to lower inflation without a recession
Goolsbee said he’s confident inflation can be tamed without a recession, even with additional rate increases likely.
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
These are the stocks posting the largest moves in midday trading.
The unemployment rate among Black workers increased in June for the second month in a row
The overall U.S. unemployment rate inched lower in June, but a negative trend in employment among Black workers may be developing.
SEC seeks rule change that could cause fund managers to take less risk
The rule change involves lowering the bar for indemnification of fund managers to “ordinary negligence” from “gross negligence.”
China hits Alibaba affiliate Ant Group with $985 million fine for violating various regulations
China’s central bank hit Alibaba affiliate Ant Group with a 7.12 billion yuan fine ($985 million) on Friday.
The No. 1 way to grow your wealth, according to a self-made millionaire: It’s ‘deceptively simple’
Growing your wealth should be boring, Ramit Sethi says. He shares three strategies that allow you to grow your money long-term.
Op-ed: Cruise line stocks are a light on the horizon for investors seeking diversification
Market breadth improved as of late May and leadership expanded to cyclical sectors. One place for investors seeking diversification could be cruise companies.
Payrolls rose by 209,000 in June, less than expected, as jobs growth wobbles
Nonfarm payrolls were expected to increase by 240,000 and the unemployment rate to fall to 3.6% in June.